WebMar 31, 2024 · Fulgent also reported estimated preliminary first quarter total revenues of $300 million, which is above previous guidance of $245 million. Upon closing, the transaction is expected to have a positive impact to pro forma EBITDA. ... and CSI’s menu of products,” said Perthuis. With the addition of Inform Diagnostics’ extensive testing ... WebAug 9, 2024 · Fulgent Genetics (NASDAQ: FLGT) has acquired CSI Laboratories to expand its presence in somatic molecular diagnostics and cancer testing. The company's shares …
Fulgent Acquires Inform Diagnostics for $170M - Inside Precision …
WebFeb 28, 2024 · Fulgent’s clinical diagnostic business offers molecular diagnostic testing services, comprehensive genetic testing, and high-quality anatomic pathology laboratory services designed to provide physicians and patients with clinically actionable diagnostic information to improve the quality of patient care. WebAug 9, 2024 · Fulgent Genetics (NASDAQ: FLGT) has acquired CSI Laboratories to expand its presence in somatic molecular diagnostics and cancer testing. The company's shares were trading down ~11% post market. clifford dog days of summer dvd
Fulgent Genetics acquires CSI laboratories Seeking Alpha
WebAug 9, 2024 · On August 9, 2024, Fulgent acquired life science company CSI Laboratories from Synergy Capital Investments. Acquisition Highlights. This is Fulgent’s 1st transaction in the Life Science sector. This is Fulgent’s 1st transaction in the United States. This is Fulgent’s 1st transaction in Georgia. WebAug 9, 2024 · Fulgent Genetics, Inc. (NASDAQ: FLGT) announced that it has acquired CSI Laboratories to expand its presence in somatic molecular diagnostics and cancer testing. CSI was founded in 1997 to provide ... WebAug 10, 2024 · Fulgent plans to use the CSI model and expertise to also build an oncology testing lab on the West Coast and establish a national footprint for the CSI business, as … board of la county tax assessor